FERRARI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 7.115
AS - Asia 5.223
EU - Europa 3.802
SA - Sud America 822
Continente sconosciuto - Info sul continente non disponibili 436
AF - Africa 130
OC - Oceania 5
Totale 17.533
Nazione #
US - Stati Uniti d'America 6.772
VN - Vietnam 1.562
IT - Italia 1.538
SG - Singapore 1.345
CN - Cina 1.063
BR - Brasile 611
HK - Hong Kong 531
DE - Germania 445
RU - Federazione Russa 406
CA - Canada 258
SE - Svezia 211
IE - Irlanda 200
GB - Regno Unito 199
FR - Francia 171
BD - Bangladesh 149
IN - India 130
UA - Ucraina 97
FI - Finlandia 96
NL - Olanda 81
ID - Indonesia 79
AR - Argentina 77
KR - Corea 70
AT - Austria 68
DK - Danimarca 64
ES - Italia 60
ZA - Sudafrica 53
MX - Messico 47
TR - Turchia 47
PL - Polonia 43
IQ - Iraq 40
CO - Colombia 37
JP - Giappone 28
PK - Pakistan 28
VE - Venezuela 27
PH - Filippine 25
SA - Arabia Saudita 24
CH - Svizzera 23
EC - Ecuador 23
BE - Belgio 18
CL - Cile 18
CZ - Repubblica Ceca 17
LT - Lituania 16
MA - Marocco 16
UZ - Uzbekistan 16
TN - Tunisia 13
JO - Giordania 12
PY - Paraguay 11
ET - Etiopia 10
JM - Giamaica 10
KE - Kenya 10
IL - Israele 9
IR - Iran 9
PE - Perù 9
MY - Malesia 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
EG - Egitto 7
KZ - Kazakistan 7
AL - Albania 6
BO - Bolivia 6
GR - Grecia 6
NP - Nepal 6
PT - Portogallo 6
RS - Serbia 6
TT - Trinidad e Tobago 6
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
CR - Costa Rica 4
HR - Croazia 4
NO - Norvegia 4
PA - Panama 4
CY - Cipro 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
OM - Oman 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
BY - Bielorussia 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
NG - Nigeria 2
NI - Nicaragua 2
SI - Slovenia 2
TW - Taiwan 2
YE - Yemen 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
EU - Europa 1
Totale 17.085
Città #
Ann Arbor 961
Singapore 772
Ashburn 710
Milan 522
Hong Kong 520
Ho Chi Minh City 448
Hanoi 429
San Jose 429
Fairfield 408
Frankfurt am Main 287
Woodbridge 273
Wilmington 248
Dallas 245
Houston 211
Chandler 199
Dublin 192
New York 186
Seattle 168
Toronto 165
Council Bluffs 152
Cambridge 144
Beijing 143
Santa Clara 138
Los Angeles 137
Hefei 135
Rome 127
Chicago 107
Dearborn 93
Jacksonville 82
Princeton 71
Shanghai 70
The Dalles 70
Dong Ket 64
Seoul 62
Buffalo 61
Lauterbourg 61
São Paulo 61
Columbus 60
Jakarta 55
Vienna 52
Haiphong 50
Helsinki 50
Nanjing 49
Moscow 43
Da Nang 41
Guangzhou 36
Montreal 35
Warsaw 35
Lawrence 34
Munich 34
Quận Bình Thạnh 33
Johannesburg 31
London 29
Turin 28
Atlanta 27
Biên Hòa 27
Hyderabad 27
San Diego 26
Altamura 25
Denver 25
Orem 25
Boardman 24
Hải Dương 24
Newark 24
Phoenix 24
Poplar 23
Rio de Janeiro 22
Nuremberg 21
Zurich 21
Stockholm 20
Turku 19
Amsterdam 17
Bologna 17
Brooklyn 17
Can Tho 17
Dhaka 17
Florence 17
Ha Long 17
Nanchang 17
Shenyang 17
Thái Nguyên 17
Baghdad 16
Brussels 16
Mexico City 16
Tokyo 16
Washington 16
Boston 15
Changsha 15
Messina 15
Piscataway 15
Sacramento 15
San Francisco 15
Andover 14
Bari 14
Genoa 14
Kent 14
Tashkent 14
Vũng Tàu 14
Brno 13
Chennai 13
Totale 10.700
Nome #
Preliminary data of ICV delivery of human Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis 1.154
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 807
Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats 396
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 389
Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis 381
Human neural stem cell transplantation in ALS: Initial results from a phase I trial 356
Mitochondrial and energy metabolism dysfunctions are hallmarks of TDP-43G376D fibroblasts from members of an Amyotrophic Lateral Sclerosis family 355
Morphological and metabolic changes in microglia exposed to cadmium: Cues on neurotoxic mechanisms 338
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 333
A link between genetic disorders and cellular impairment, using human induced pluripotent stem cells to reveal the functional consequences of copy number variations in the central nervous system—a close look at chromosome 15 319
Production and characterization of human induced pluripotent stem cells (iPSC) CSSi007-A (4383) from Joubert Syndrome 318
Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies 312
Immortalization of human neural stem cells with the c-myc mutant T58A 308
Generation and characterization of a patient-derived iPSC line, CSSi022-A (15666), with a pathogenic MFN2 mutation causing Charcot-Marie-Tooth disease type 2A 301
Mild hypoxia enhances proliferation and multipotency of human neural stem cells 298
Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile Huntington Disease 285
Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy 284
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 275
Preliminary data of intracerebroventricular transplantation of human-Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis 273
Recent therapeutic advances in the treatment and management of amyotrophic lateral sclerosis: the era of regenerative medicine 273
Retrieval of germinal zone neural stem cells from the cerebrospinal fluid of premature infants with intraventricular hemorrhage 271
Neural stem cells and human induced pluripotent stem cells to model rare CNS diseases 265
Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA) 262
Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene 261
Production and characterization of human induced pluripotent stem cells (iPSCs) from Joubert Syndrome: CSSi001-A (2850) 261
Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein 258
Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice. 257
Adult stem cell as new advanced therapy for experimental neuropathic pain treatment 257
Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno-1) after transplantation 257
Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage 254
Human Fetal Neural Stem Cells for Neurodegenerative Disease Treatment 253
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease 252
Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein 252
Induced pluripotent stem cell production (CSSi019-A)(14432) from an asymptomatic subject carrying a expansion of C9orf72 gene 251
Isolation of neural stem cells from neural tissues using the neurosphere technique 248
Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression 248
Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model 246
Unique expression and localization of aquaporin-4 and aquaporin-9 in murine and human neural stem cells and in their glial progeny 239
Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization 235
Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene 234
Advances in stem cell therapy for amyotrophic lateral sclerosis 234
Exploring the metabolic signature of ALS patients-derived cells 231
Production and characterization of CSSI003 (2961) human induced pluripotent stem cells (iPSCs) carrying a novel puntiform mutation in RAI1 gene, Causative of Smithâ Magenis syndrome 228
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 224
Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome 224
Exploring the metabolic signature of Amyotrophic Lateral Sclerosis patients-derived cells 221
Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome region 217
Generation of an induced pluripotent stem cell line CSSi015-A (9553), carrying a point mutation c.2915C > T in the human calcium sensing receptor (CasR) gene 213
Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A) 212
Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7 207
Functional outcomes of copy number variations of Chrna7 gene: Current knowledge and new insight from induced pluripotent stem cells studies 201
Safety and efficacy evaluation of intracerebroventricular human neural stem cell transplantation in SOD1 mice as a novel approach for ALS 199
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft 195
Generation and characterization of the CSSi021-A (15665) human induced pluripotent stem cell line from a Smith-Magenis syndrome patient with a heterozygous RAI1 mutation 191
Inorganic mercury changes the fate of murine CNS stem cells 191
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease 185
Unraveling the impact of human cerebrospinal fluid on human neural stem cell fate 184
Culturing and Expansion of “Clinical Grade” Neural Stem Cells from the Fetal Human Central Nervous System 181
The stem cells as a potential treatment for neurodegeneration 176
INTERROGATING ALS SIGNATURE IN HUMAN INDUCED NEURAL STEM CELLS 169
INTERROGATING ALS SIGNATURE IN EARLY NEURAL PROGENITOR CELLS: A DIFFERENT PERSPECTIVE 167
Uncovering primary cilium defects in Joubert Syndrome using iPSCs derived-Neural Stem Cells 141
Brain Organoids to Evaluate Cellular Therapies 139
Traffic-related diesel pollution particles impair the lysosomal functions of human iPSC-derived microglia 99
Generation and characterization of the hiPSC line CSSi023-A (16154) from a patient with ADOA caused by an OPA1 variant 24
Modelling a TARDBP-ALS Family in iPSC-Derived Neural Stem Cells Uncovers Metabolic and Proliferative Defects 21
Mutant Huntingtin disrupts neurogenic and astroglial programs via the EZH2–Let-7g–LIN28 axis with rescue by epigenetic modulators 16
Interrogating Amyotrophic Lateral Sclerosis Signatures in TDP-43G376D human induced Neural Stem Cells 16
Dissecting TDP-43 loss- and gain-of-function to understand selective motor neuron vulnerability in ALS 11
Totale 17.533
Categoria #
all - tutte 51.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.365


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022544 0 82 75 27 20 40 48 72 30 27 58 65
2022/20231.057 89 269 139 111 93 147 10 51 58 23 39 28
2023/2024909 26 29 56 73 103 188 148 42 68 35 32 109
2024/20253.666 126 195 242 138 183 123 156 110 302 430 251 1.410
2025/20267.078 669 680 547 817 763 357 852 318 588 678 368 441
2026/2027589 200 389 0 0 0 0 0 0 0 0 0 0
Totale 17.533